Interest in using weight-loss medications Among participants who had not used a GLP-1, GLP-1/GIP, or other medication for weight loss in the past year (96.0% [95.596.6%] of the sample), 6.5% [5.77.3%] said they would be likely to consider using a weight-loss medication in the next year (2.5% [2.13.0%] very likely and 4.0% [3.44.6%] fairly likely
Disentangling heterogeneity in alzheimers disease and related dementias using data-driven methods
All our programs are administered under the strict supervision of medical professionals who can manage any potential side effects and adjust your plan as you progress
Patients in trials reported less breathlessness, better ability to walk or exercise, improved quality of life scores, weight loss, and better functional capacity
Hydration, B6, probiotics, and digestive enzymes function best when taken regularly rather than only during symptoms